All news

Humana hits 52-week high after Q3 beat and raised outlook

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Humana Inc. (NYSE: HUM) reached a new 52-week high of $459.53, a 96.24% gain over the past year. Piper Sandler, Raymond James, Mizuho and Jefferies adjusted price targets and reaffirmed ratings after better-than-expected Q3 results and a raised full-year earnings outlook, with most maintaining a positive stance despite some investor caution.

Read original source

HUM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.